Evaluate the Depth and Duration of Anesthesia

Phase 4 Completed 25 enrolled ZARS Pharma Inc. Endo USA Inc., a Keenova Therapeutics Company · collab

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing and thermal sensory testing evaluations), compared with a matching heated placebo patch.

Timeline

Start: 2006-12
Primary completion: 2007-04
Completion: 2007-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lidocaine	Other / unclassified	70 mg	Topical
Subject	tetracaine	Other / unclassified	70 mg	Topical

Indications

No indication recorded.